Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026)
Acadia Pharmaceuticals' Other Non Operating Income was $647,000 in Q2 2026, up 8.9% from $594,000 a year earlier and up 19.4% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' Other Non Operating Income was $2.38 million through Jun 30, 2026, up 1.9% year-over-year; for FY2025, it was $2.37 million, up 30.1% from FY2024.
- In earlier years, Other Non Operating Income was $1.82 million in FY2024 (-64.3%), $5.11 million in FY2023 (+44.2%), $3.54 million in FY2022 (+52.1%) and $2.33 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Other Non Operating Income since Q3 2023.
- Compared with a year earlier, Other Non Operating Income was higher in five of the last seven quarters, with growth averaging 15.1%.
- The best year-over-year quarter for Other Non Operating Income over five years was Q4 2021 (growth of 512.5%); the worst was Q1 2024 (a decline of 94.1%).
- Per Business Quant data, ACAD's Other Non Operating Income in the three quarters before Q2 2026 was $542,000 (Q1 2026), $596,000 (Q4 2025) and $593,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.50 Bn | 21.37 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 647,000.00 |
| Mar 31, 2026 | 542,000.00 |
| Dec 31, 2025 | 596,000.00 |
| Sep 30, 2025 | 593,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 286,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | 4.85 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | -497,000.00 |
| Mar 31, 2022 | 340,000.00 |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 383,000.00 |
| Jun 30, 2021 | 178,000.00 |
API Access
Acadia Pharmaceuticals Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();